skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong Pharmaceuticals presents result of phase 3 clinical trial on Supect at The Korean Society of Hematology
Date 2016-05-31 Hit 8395
News List
Prev Daewoong Pharmaceuticals receives Prime Minister Commendation as an ‘Outstanding Company in Fair Gender Employment’
Next Daewoong Pharmaceutical signs export contract to New Zealand and Israel with Nabota